Vascular access is any method used to reach the bloodstream so that fluids, medications, blood products, or nutrition can be delivered directly into circulation, or so that blood can be drawn or filtered. It ranges from the familiar IV line taped to your hand during a hospital stay to surgically created connections between arteries and veins that last for years. The type of access a patient needs depends on what is being infused, how long treatment will last, and how urgently the access is required, and getting this choice right matters more than most people realize.
The Standard IV Line and Its Limits
The most common form of vascular access is the short peripheral intravenous catheter, the small plastic tube a nurse slides into a vein on your hand or forearm. These are used billions of times a year worldwide for hydration, antibiotics, pain medication, and blood draws. They are quick to place, relatively painless, and work well for short treatments. But they come with a built-in clock.
Research has shown that the risk of complications from short peripheral catheters does not necessarily increase when they are replaced based on clinical signs of trouble rather than on a fixed schedule, though in most studies the average time these catheters stayed in place did not exceed about three and a half days.1PubMed. Short Peripheral Catheter Dwell Time and Associated Complications: A Systematic Review A larger study looking specifically at bloodstream infections found that the risk jumped sharply after three days, with the odds of infection more than thirteen times higher once the catheter had been in place that long.2JAMA Network Open. Dwell Time and Risk of Bloodstream Infection With Peripheral Intravenous Catheters That elevated risk persisted at four, five, and six days as well. So while there is no universal rule that every IV must come out at 72 hours, the evidence makes clear that leaving one in for a week is pushing your luck.
This time limit is the main reason peripheral IVs are not the answer for every patient. If you need intravenous antibiotics for six weeks to treat a bone infection, or chemotherapy that will cycle over months, a standard IV is simply not built for the job.
Midline Catheters for Medium-Duration Treatment
When treatment will last longer than a few days but the medications involved are mild enough to flow through smaller veins, a midline catheter fills the gap. A midline is a longer catheter inserted into a vein in the upper arm, with its tip resting in a large vein below the armpit rather than advancing all the way into the chest. It is more stable than a short IV and can stay in place considerably longer.
In a randomized trial comparing midlines to standard peripheral IVs, midline catheters lasted an average of about eight days compared to roughly three days for peripheral catheters, and the midline group developed fewer complications like phlebitis.3PubMed Central. Usefulness of Midline Catheters versus Peripheral Venous Catheters in an Inpatient Unit: A Pilot Randomized Clinical Trial That makes midlines useful for patients receiving a week or two of IV fluids or peripheral-compatible drugs, particularly those with veins that are already damaged from repeated needle sticks.
There are important restrictions, however. Because the catheter tip sits in a peripheral vein, not a large central vein, midlines are not appropriate for medications that could damage smaller vessel walls. Vesicant drugs, parenteral nutrition formulas, and infusions with extreme pH or very high concentrations should not be run through midline catheters.4PubMed. Infiltration and Extravasation Risk with Midline Catheters: A Narrative Literature Review
Central Venous Catheters
When medications are too harsh for peripheral veins, when multiple drugs need to run simultaneously, or when treatment will stretch across weeks or months, the catheter tip needs to sit in one of the body’s large central veins near the heart. Central venous catheters come in several varieties, each suited to a different clinical situation.
A non-tunneled central line is the workhorse of intensive care units. It is inserted directly through the skin into a large vein in the neck, chest, or groin, and it can have multiple channels, called lumens, allowing several medications and fluids to flow at the same time. Non-tunneled lines are generally used for treatment lasting up to about two to three weeks.5PubMed Central. Central venous catheters: Which, when and how CVC review They are essential in critical care for delivering vasopressor medications that maintain blood pressure, concentrated nutrition, and chemotherapy that would destroy a smaller vein.
A peripherally inserted central catheter, or PICC, is threaded from a vein in the upper arm all the way into the large central veins near the heart. Because the insertion site is in the arm rather than the neck or chest, PICCs are easier to place and manage, and they are commonly used for treatment lasting up to about three months.5PubMed Central. Central venous catheters: Which, when and how CVC review They are the standard choice for patients going home with weeks of IV antibiotics or chemotherapy, since a visiting nurse or even the patient can manage them outside the hospital.
Tunneled central catheters, such as Hickman or Broviac lines, take a different approach. The catheter is threaded under the skin for several inches before entering a vein, and a small cuff under the skin encourages tissue to grow around it, anchoring it in place and creating a barrier against infection. Tunneled lines are designed for use lasting more than a month and sometimes for years.5PubMed Central. Central venous catheters: Which, when and how CVC review They are commonly seen in patients receiving long courses of chemotherapy, prolonged antibiotic therapy, or regular blood transfusions.
Implanted Ports for Long-Term Treatment
For patients facing the longest treatment timelines, particularly in cancer care, a totally implanted venous access port offers a different trade-off. A port is a small reservoir, roughly the size of a coin, that a surgeon places beneath the skin of the chest. A catheter runs from the port into a central vein. When treatment is needed, a special needle is pushed through the skin into the port’s rubber septum; when treatment is done, the needle is removed and nothing is visible from the outside.
Ports are popular for chemotherapy that cycles over many months or years because they require minimal maintenance between treatments, there is no external catheter to manage, and patients can shower, swim, and exercise without restriction. A four-year study of port catheters in oncology patients found that the devices maintained function for an average of about 375 days, with relatively few complications. Among 171 patients, only nine developed infections, and just two required early removal for severe infection. Major complications like nerve injury, large hematomas, or catheter fracture did not occur.6Acta Medica Alanya. Four-Year Study on Subcutaneous Port Catheters in Oncology Patients: Patency, Complications, and Outcomes The evidence supports starting chemotherapy through the port almost immediately after implantation.7PubMed Central. Safety of immediate use of totally implantable venous access ports in adult patients with cancer: a retrospective single-center study
The downside is that ports require a minor surgical procedure to implant and another to remove, and the initial cost is higher than for other central lines. Over a long treatment course, though, the low complication rate and minimal ongoing maintenance tend to offset those upfront costs.8Annals of Oncology. Totally implantable central venous access ports for long-term chemotherapy
Hemodialysis Access Is a Category of Its Own
Patients with kidney failure who need regular hemodialysis present a unique vascular access challenge. A dialysis machine needs to pull blood out of the body at a high flow rate, clean it, and return it, typically three times a week for years. No standard IV line or even a central catheter handles that kind of sustained, high-volume traffic well. Dialysis patients need a purpose-built connection.
The preferred option is an arteriovenous fistula, or AVF, created by surgically connecting an artery to a vein, usually in the forearm or upper arm. The high-pressure arterial blood flow causes the vein to enlarge and thicken over weeks or months, eventually becoming strong enough to withstand repeated needle insertions. An alternative is an arteriovenous graft, or AVG, where a synthetic tube bridges the gap between artery and vein, creating a similar connection that can typically be used sooner.
Both options work, but they come with different trade-offs. Upper arm fistulas take longer to mature before first use, roughly four months compared to under two months for forearm grafts. However, fistulas have a significantly lower complication rate. In one comparative study, complications occurred in about 42% of fistula patients versus 65% of graft patients, and thrombosis, or clotting of the access, was more than twice as common with grafts.9PubMed. Upper arm arteriovenous fistula versus forearm looped arteriovenous graft for hemodialysis access: a comparative analysis About half of all fistulas need some kind of intervention to help them mature properly, and those that do tend to have shorter functional lifespans than fistulas that mature on their own.10PubMed Central. Outcomes of arteriovenous fistulas and grafts with or without intervention prior to successful use This is why planning for dialysis access ideally starts months before a patient actually needs it.
Emergency Access When Veins Fail
In emergencies like cardiac arrest, severe trauma, or shock, getting medications and fluids into the bloodstream is a matter of minutes. If a patient’s veins have collapsed from blood loss or dehydration and a standard IV line cannot be placed quickly, clinicians turn to intraosseous access. An intraosseous needle is drilled through the outer layer of bone, usually into the shin or the upper arm, reaching the marrow cavity. The bone marrow is rich in tiny blood vessels that drain directly into the central circulation, so fluids and drugs delivered this way reach the heart almost as quickly as through a traditional IV.
Intraosseous access provides fast, reliable vascular access in emergencies and is used as a temporary bridge when peripheral or central venous routes cannot be established.11PubMed. Insertion of an Intraosseous Needle in Adults Modern spring-loaded and battery-powered drill devices have made the technique faster and more consistent, lowering the threshold for using it in both adults and children.12PubMed Central. Emergency intraosseous access in a helicopter emergency medical service: a retrospective study A retrospective study of intraosseous access during resuscitation found high success rates for infusion regardless of patient age, weight, or the specific bone site chosen, with minimal complications.13PubMed Central. Effectiveness of intraosseous access during resuscitation: a retrospective cohort study It is not intended for long-term use, but in the critical first minutes of a resuscitation, it can be lifesaving.
Arterial Lines for Monitoring, Not Infusion
Not all vascular access is about delivering medications. Arterial lines are thin catheters placed in an artery, usually at the wrist, and they serve a different purpose: continuous, beat-by-beat blood pressure monitoring and easy blood sampling for arterial blood gas analysis. They are standard in intensive care units and operating rooms for unstable patients.
Arterial access is also increasingly used in prehospital emergency medicine. A study of critically ill patients transported by emergency services found that the most common reasons for placing an arterial line in the field were the use of blood-pressure-supporting medications, airway management, and aggressive fluid resuscitation.14PubMed Central. Implementing prehospital invasive arterial blood pressure monitoring in critically ill patients-a prospective observational first year analysis Unlike venous access, arterial lines are almost never used to infuse drugs. Their value is in the real-time data they provide, allowing clinicians to adjust treatment moment by moment.
How the Medication Itself Dictates Device Choice
One of the most underappreciated factors in vascular access decisions is what exactly is being infused. Medications vary widely in how acidic or alkaline they are, how concentrated they are, and whether they can damage tissue if they leak out of the vein. These properties directly determine which device is safe to use.
An expert panel categorized common intravenous drug preparations by their tissue-damage risk based on concentration, acidity, and vesicant properties. Roughly 40% of the drug preparations they evaluated fell into the high-risk category, meaning their extreme concentration or pH could injure vessel walls or surrounding tissue.15PubMed Central. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety High-risk infusions need central venous access, where the large vessel diameter and high blood flow dilute the medication rapidly. Running a vesicant drug through a small peripheral vein risks extravasation, where the drug leaks into surrounding tissue and can cause severe damage or even tissue death.
A multispecialty panel that developed guidelines for catheter appropriateness evaluated hundreds of clinical scenarios, weighing the type of infusion against the planned duration and the patient’s overall condition. Of 665 scenarios they reviewed, only about 38% were rated as clearly appropriate for PICCs, while 43% were rated as inappropriate, often because a simpler peripheral device would have been sufficient or because the patient’s condition made a PICC risky.16PubMed. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method The takeaway for patients is that a more advanced catheter is not always better. Using the least invasive device that can safely do the job reduces risk.
Infection, Clots, and How They Are Prevented
The two major complications of vascular access are infection and blood clots, and both become more likely the longer a device stays in place and the larger the catheter. Central line-associated bloodstream infections were once a leading cause of preventable hospital deaths, but standardized prevention bundles have dramatically reduced their incidence. These bundles combine hand hygiene, full sterile barriers during insertion, skin disinfection with chlorhexidine, avoidance of high-risk insertion sites like the groin, and prompt removal of catheters that are no longer needed.17International Journal of Nursing and Medical Investigation. Central Line-associated Bloodstream Infections: CLABSI Care Bundle Approach of Prevention In dedicated implementation programs, some intensive care units have achieved sustained periods with zero central line infections.18PubMed Central. Bundle approach used to achieve zero central line-associated bloodstream infections in an adult coronary intensive care unit
Catheter-related thrombosis, where a blood clot forms on or around the catheter, is a common complication of central venous devices, particularly PICCs. Patients in critical care often have multiple overlapping risk factors for clotting, and as PICC use has grown, so has the incidence of catheter-related clots.19PubMed Central. Catheter-related thrombosis: A practical approach This is another reason why choosing the smallest, shortest-duration device appropriate for the clinical situation matters. A patient who only needs five days of IV antibiotics through a peripheral-compatible drug does not benefit from having a PICC placed “just in case.”
Ultrasound Guidance Has Changed the Game
One of the biggest practical advances in vascular access over the past two decades is the routine use of ultrasound to guide catheter placement. For patients with difficult veins, whether because of obesity, dehydration, chronic illness, or a history of IV drug use, placing a peripheral IV by feel alone can mean multiple painful failed attempts.
A meta-analysis of emergency department patients with difficult IV access found that ultrasound-guided placement nearly doubled the first-attempt success rate compared to traditional techniques.20PubMed Central. The efficacy of ultrasound-guided peripheral intravenous cannulation versus the landmark technique in emergency department patients with difficult intravenous access: A systematic review and meta-analysis In a randomized trial of adults with difficult access, the first-attempt success rate was about 64% with ultrasound versus roughly 14% without it.21PubMed Central. Recent Advances in Ultrasound-Guided Peripheral Intravenous Catheter Insertion In pediatric patients, where veins are small and cooperation is limited, ultrasound boosted first-attempt success to about 86% compared to 33% with standard techniques.21PubMed Central. Recent Advances in Ultrasound-Guided Peripheral Intravenous Catheter Insertion
Beyond peripheral IVs, ultrasound has become the standard of care for selecting vessels, choosing catheter size, guiding placement, and avoiding complications during central line and PICC insertion.22PubMed Central. Vascular access in children For patients, the practical result is fewer needle sticks, less bruising, and faster access to treatment.
Dedicated Vascular Access Teams
Hospitals that have created specialized vascular access teams, groups of nurses and technicians who focus exclusively on placing and managing IV catheters, report better outcomes than settings where any available clinician handles the task. One hospital’s experience with a dedicated team found a 95.6% first-attempt success rate for catheter insertion and estimated annual savings approaching €868,000, driven by reduced catheter-related complications and shorter hospital stays.23PubMed Central. Implementation of a vascular access team and an intravenous therapy programme: A first-year activity analysis
Specialized teams also use technology like intracavitary electrocardiography to confirm PICC tip position at the bedside rather than relying on a post-insertion chest X-ray. This approach has been shown to be safe, effective, and cost-saving compared to conventional placement methods that require radiology confirmation.24PubMed. Clinical and economic impact of vascular access teams utilizing an IC-ECG-based tip confirmation system for peripherally inserted central catheters For patients, it means the catheter is usable sooner and the process involves less waiting around.
Vascular Access in Children and Newborns
Pediatric vascular access is a distinct challenge. Veins in infants and small children are tiny, often invisible, and surrounded by more subcutaneous fat. Children are also, understandably, uncooperative with needles. The same device categories apply, ranging from peripheral IVs to central lines to intraosseous needles, but the technical difficulty is higher at every level.
Intraosseous access is considered a lifesaving technique in pediatric emergencies, particularly in children with severe dehydration or shock where veins have collapsed.22PubMed Central. Vascular access in children Technologies like transillumination, where a bright light is placed against the skin to make superficial veins glow, and near-infrared vein finders help clinicians locate vessels that are invisible to the naked eye. For long-term access devices in children, fluoroscopy, a type of real-time X-ray, is used during insertion to ensure correct placement.
The emotional burden on pediatric patients and their families is real. Repeated failed IV attempts are one of the most distressing experiences children report during hospitalization, which is part of why the push for ultrasound-guided placement and specialized pediatric vascular access teams has gained momentum. Getting it right on the first try is not just a technical metric. For a frightened child and an anxious parent, it changes the entire experience of care.
The Seldinger Technique and Why It Matters
Nearly every central venous catheter, arterial line, and PICC placed today uses a technique developed in the 1950s by a Swedish radiologist. The approach involves inserting a thin needle into the vessel, threading a flexible guidewire through the needle, removing the needle, and then sliding the catheter over the wire into position. Before this method existed, gaining access to deep blood vessels required surgical incisions and direct exposure of the vessel, a far more invasive process.25PubMed Central. Sven Ivar Seldinger (1921-1998): The Founding Father of Interventional Radiology
This wire-guided approach made minimally invasive vascular access possible and laid the groundwork for interventional radiology as an entire medical specialty. It is one of those innovations that became so universal that most patients have never heard of it, even though they have almost certainly benefited from it. If you have ever had a PICC line or a central catheter placed without an open surgical incision, the Seldinger technique is why.